Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenkang Decoction
- Development stage
- Phase 1
- Lead developer
- Zunyi First People's Hospital
- Administration
- Oral
01
Overview
Shenkang Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily used for the treatment of chronic renal failure (CRF) and chronic kidney disease (CKD). It typically consists of a combination of botanical ingredients, including *Rheum palmatum* (Rhubarb), *Salvia miltiorrhiza* (Red Sage), *Astragalus membranaceus* (Astragalus), and *Carthamus tinctorius* (Safflower). The decoction is intended to improve renal function, reduce levels of serum creatinine and blood urea nitrogen (BUN), and delay the progression of kidney disease. It is often used as an adjuvant therapy alongside standard treatments like hemodialysis. Clinical trials, such as those conducted by the First People's Hospital of Zunyi, have evaluated its efficacy in improving clinical outcomes for patients with chronic renal failure undergoing hemodialysis.
- Brand names
- Shenkang Granules
- Other names
- Shenkang Tangshenkang granules
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)C-C motif chemokine ligand 2 (CCL2)/C-C chemokine receptor type 2 (CCR2) axis
Beyond the preview
Go deeper on Shenkang Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenkang Decoction.